Adaptive Biotechnologies (ADPT) FCF Margin (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted FCF Margin of 14.58% for Q1 2026, down 4328.24% sequentially from 0.33% in Q4 2025, and up 4014.0% YoY from 0.35% in Q1 2025.
Adaptive Biotechnologies (ADPT) FCF Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of FCF Margin data on file, last reported at 14.58% in Q1 2026.
- Quarterly FCF Margin rose 4014.0% year-over-year to 14.58% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.35% (up 3613.0% YoY) and the FY2025 annual result came in at 17.67%, up 3758.0% from the prior year.
- FCF Margin declined to 14.58% in Q1 2026 per ADPT's latest filing, from 0.33% in the prior quarter.
- The five-year high for FCF Margin was 0.33% in Q4 2025, with the low at 370.47% in Q2 2023.
- Average FCF Margin over 5 years is 85.02%, with a median of 57.47% recorded in 2023.
- Year-over-year, FCF Margin tumbled 26219 bps in 2023 and soared 32548 bps in 2024.
- Adaptive Biotechnologies' FCF Margin stood at 52.75% in 2022, then dropped by 9 bps to 57.47% in 2023, then soared by 54 bps to 26.49% in 2024, then soared by 99 bps to 0.33% in 2025, then tumbled by 4328 bps to 14.58% in 2026.
- Business Quant data shows ADPT's FCF Margin at 14.58% in Q1 2026, 0.33% in Q4 2025, and 8.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.31% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 7.41% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 18.23% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 22.61% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 2.59% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 10.95% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 11.83% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 23.01% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 12.92% |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -14.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.58% |
| Dec 31, 2025 | -0.33% |
| Sep 30, 2025 | -8.06% |
| Jun 30, 2025 | -21.13% |
| Mar 31, 2025 | -54.72% |
| Dec 31, 2024 | -26.49% |
| Sep 30, 2024 | -59.03% |
| Jun 30, 2024 | -44.98% |
| Mar 31, 2024 | -94.26% |
| Dec 31, 2023 | -57.47% |
| Sep 30, 2023 | -109.10% |
| Jun 30, 2023 | -370.47% |
| Mar 31, 2023 | -161.51% |
| Dec 31, 2022 | -52.75% |
| Sep 30, 2022 | -87.27% |
| Jun 30, 2022 | -108.28% |
| Mar 31, 2022 | -174.86% |
| Dec 31, 2021 | -122.26% |
| Sep 30, 2021 | -34.70% |
| Jun 30, 2021 | -153.89% |